Literature DB >> 11575471

Relationship between complement activation, cellular uptake and surface physicochemical aspects of novel PEG-modified nanocapsules.

V C Mosqueira1, P Legrand, A Gulik, O Bourdon, R Gref, D Labarre, G Barratt.   

Abstract

The aim of our work was to examine the relationship between modifications of the surface of nanocapsules (NC) by adsorption or covalent grafting of poly(ethylene oxide) (PEG), and changes in their phospholipid (PL) content on complement activation (C3 cleavage) and on uptake by macrophages. The physicochemical characterization of the NC included an investigation of their properties, such as surface charge, size, hydrophilicity, morphology and homogeneity. This is the first time that such properties have been correlated with biological interactions for NC, a novel carrier system with a structure more complex than nanospheres. C3 crossed immunoelectrophoresis revealed the reduced activation for NC with longer PEG chain and higher density, although all formulations induced C3 cleavage to a lesser or greater extent. NC bearing PEG covalently bound to the surface were weaker activators of complement than plain PLA [poly(D,L-lactide)] NC or nanospheres (NS). Furthermore, the fluorescent/confocal microscopy of J774A1 cells in contact with NC reveal a dramatically reduced interaction with PEG-bearing NC. However, the way in which PEG was attached (covalent or adsorbed) seemed to affect the mechanism of uptake. Taken together, these results suggest that the low level of protein binding to NC covered with a high density of 20kDa PEG chains is likely to be due to the steric barriers surrounding these particles, which prevents protein adsorption and reduces their interaction with macrophages.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11575471     DOI: 10.1016/s0142-9612(01)00043-6

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  47 in total

1.  Effects of block copolymer properties on nanocarrier protection from in vivo clearance.

Authors:  Suzanne M D'Addio; Walid Saad; Steven M Ansell; John J Squiers; Douglas H Adamson; Margarita Herrera-Alonso; Adam R Wohl; Thomas R Hoye; Christopher W Macosko; Lawrence D Mayer; Christine Vauthier; Robert K Prud'homme
Journal:  J Control Release       Date:  2012-06-23       Impact factor: 9.776

Review 2.  Drug transport to brain with targeted nanoparticles.

Authors:  Jean-Christophe Olivier
Journal:  NeuroRx       Date:  2005-01

3.  Kinetics of protein adsorption and desorption on surfaces with grafted polymers.

Authors:  Fang Fang; Javier Satulovsky; Igal Szleifer
Journal:  Biophys J       Date:  2005-07-01       Impact factor: 4.033

4.  Fc microparticles can modulate the physical extent and magnitude of complement activity.

Authors:  Brandon Alexander Holt; Michael C Bellavia; Daniel Potter; David White; Sean R Stowell; Todd Sulchek
Journal:  Biomater Sci       Date:  2017-02-28       Impact factor: 6.843

5.  Cholesterol-tethered platinum II-based supramolecular nanoparticle increases antitumor efficacy and reduces nephrotoxicity.

Authors:  Poulomi Sengupta; Sudipta Basu; Shivani Soni; Ambarish Pandey; Bhaskar Roy; Michael S Oh; Kenneth T Chin; Abhimanyu S Paraskar; Sasmit Sarangi; Yamicia Connor; Venkata S Sabbisetti; Jawahar Kopparam; Ashish Kulkarni; Katherine Muto; Chitra Amarasiriwardena; Innocent Jayawardene; Nicola Lupoli; Daniela M Dinulescu; Joseph V Bonventre; Raghunath A Mashelkar; Shiladitya Sengupta
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-25       Impact factor: 11.205

Review 6.  Chemical basis of interactions between engineered nanoparticles and biological systems.

Authors:  Qingxin Mu; Guibin Jiang; Lingxin Chen; Hongyu Zhou; Denis Fourches; Alexander Tropsha; Bing Yan
Journal:  Chem Rev       Date:  2014-06-13       Impact factor: 60.622

7.  In vivo biodistribution and clearance studies using multimodal organically modified silica nanoparticles.

Authors:  Rajiv Kumar; Indrajit Roy; Tymish Y Ohulchanskky; Lisa A Vathy; Earl J Bergey; Munawwar Sajjad; Paras N Prasad
Journal:  ACS Nano       Date:  2010-02-23       Impact factor: 15.881

8.  Determination of the in vivo degradation mechanism of PEGDA hydrogels.

Authors:  M B Browning; S N Cereceres; P T Luong; E M Cosgriff-Hernandez
Journal:  J Biomed Mater Res A       Date:  2014-02-13       Impact factor: 4.396

9.  Novel polysaccharide-decorated poly(isobutyl cyanoacrylate) nanoparticles.

Authors:  Cédric Chauvierre; Denis Labarre; Patrick Couvreur; Christine Vauthier
Journal:  Pharm Res       Date:  2003-11       Impact factor: 4.200

Review 10.  Factors affecting the clearance and biodistribution of polymeric nanoparticles.

Authors:  Frank Alexis; Eric Pridgen; Linda K Molnar; Omid C Farokhzad
Journal:  Mol Pharm       Date:  2008-08-04       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.